Current state and perspectives of stem cell therapy for stroke

D.M. Martínez-Garza , O.G. Cantú-Rodríguez , J.C. Jaime-Pérez , C.H. Gutiérrez-Aguirre , J.F. Góngora-Rivera , D. Gómez-Almaguer
{"title":"Current state and perspectives of stem cell therapy for stroke","authors":"D.M. Martínez-Garza ,&nbsp;O.G. Cantú-Rodríguez ,&nbsp;J.C. Jaime-Pérez ,&nbsp;C.H. Gutiérrez-Aguirre ,&nbsp;J.F. Góngora-Rivera ,&nbsp;D. Gómez-Almaguer","doi":"10.1016/j.rmu.2016.07.005","DOIUrl":null,"url":null,"abstract":"<div><p>Stroke represents a public health enemy. Currently, and in spite of multiple clinical trials, thrombolysis remains as the only approved therapy. Most preclinical trials and animal trials employing stem cell-based therapies have shown very promising evidence of benefits. The aim of this review is to provide a landscape of what has been done in human clinical trials, and what are the possible ways that stem cell therapy may enhance functional recovery in stroke patients.</p></div>","PeriodicalId":34640,"journal":{"name":"Medicina Universitaria","volume":"18 72","pages":"Pages 169-180"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmu.2016.07.005","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Universitaria","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665579616300710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Stroke represents a public health enemy. Currently, and in spite of multiple clinical trials, thrombolysis remains as the only approved therapy. Most preclinical trials and animal trials employing stem cell-based therapies have shown very promising evidence of benefits. The aim of this review is to provide a landscape of what has been done in human clinical trials, and what are the possible ways that stem cell therapy may enhance functional recovery in stroke patients.

干细胞治疗中风的现状与展望
中风是公共卫生的大敌。目前,尽管有多项临床试验,溶栓仍然是唯一被批准的治疗方法。大多数采用干细胞疗法的临床前试验和动物试验都显示出非常有希望的益处。这篇综述的目的是提供一个在人类临床试验中已经完成的景观,以及干细胞治疗可能增强中风患者功能恢复的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
30
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信